ISRCTN76376497已完成不适用
A randomized, prospective, double-blind, placebo-controlled evaluation of the effect of sedation on combined diagnostic cervical and lumbar facet joint nerve blocks
Institutional Review Board of Ambulatory Surgery Center (USA)0 个研究点目标入组 60 人开始时间: 2005年6月22日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Subjects between 18 and 90 years of age
- •2. Subjects with a history of chronic, function limiting, low back and neck pain of at least 6 months in duration
- •3. Subjects who are able to give voluntary, written informed consent to participate in this investigation
- •4. Subjects who, in the opinion of the investigator, are able to understand this investigation, and/or co-operate with the investigational procedures
- •5. Subjects should have undergone diagnostic facet joint blocks and the combined diagnostic cervical and lumbar facet joint pain has been confirmed previously
排除标准
- •1. Absence of combined cervical and lumbar facet joint pain
- •2. Uncontrolled major depression or uncontrolled psychiatric disorders
- •3. Women who are pregnant or lactating
- •4. Patients with multiple complaints involving multiple other problems which have overlapping pain complaints
- •5. Inability to achieve appropriate positioning and inability to understand informed consent and protocol
- •6. History of adverse reaction to either midazolam or fentanyl
研究者
相似试验
进行中（未招募）
1 期
A 5-month research project for children aged from 1 year to 17 years who have high blood pressure in the lung, to see how well bosentan decreases this high blood pressure and improves children's physical capabilities compared to an inactive compoundPulmonary arterial hypertension (PAH) in childrenMedDRA version: 14.1Level: LLTClassification code 10064908Term: Associated with (APAH)System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 14.1Level: LLTClassification code 10064909Term: Idiopathic (IPAH)System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 14.1Level: LLTClassification code 10064910Term: Familial (FPAH)System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2011-004106-16-FRActelion pharmaceuticals Ltd105
进行中（未招募）
1 期
A 5-month research project for children aged from 1 year to 17 years who have high blood pressure in the lung, to see how well bosentan decreases this high blood pressure and improves children's physical capabilities compared to an inactive compoundPulmonary arterial hypertension (PAH) in childrenMedDRA version: 14.1Level: LLTClassification code 10064908Term: Associated with (APAH)System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 14.1Level: LLTClassification code 10064909Term: Idiopathic (IPAH)System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 14.1Level: LLTClassification code 10064910Term: Familial (FPAH)System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2011-004106-16-BGActelion pharmaceuticals Ltd105
进行中（未招募）
不适用
A 5-month research project for children aged from 1 year to 17 years who have high blood pressure in the lung, to see how well bosentan decreases this high blood pressure and improves children's physical capabilities compared to an inactive compoundPulmonary arterial hypertension (PAH) in childrenMedDRA version: 14.1Level: LLTClassification code 10064910Term: Familial (FPAH)System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 14.1Level: LLTClassification code 10064909Term: Idiopathic (IPAH)System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 14.1Level: LLTClassification code 10064908Term: Associated with (APAH)System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2011-004106-16-PTActelion pharmaceuticals Ltd105
进行中（未招募）
1 期
A 5-month research project for children aged from 1 year to 17 years who have high blood pressure in the lung, to see how well bosentan decreases this high blood pressure and improves children's physical capabilities compared to an inactive compoundPulmonary arterial hypertension (PAH) in childrenMedDRA version: 14.1Level: LLTClassification code 10064908Term: Associated with (APAH)System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 14.1Level: LLTClassification code 10064909Term: Idiopathic (IPAH)System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 14.1Level: LLTClassification code 10064910Term: Familial (FPAH)System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2011-004106-16-NLActelion pharmaceuticals Ltd105
招募中
1 期
Investigation of AV411 in neuropathic paiDiabetic neuropathy or Complex regional pain syndromeMetabolic and Endocrine - DiabetesNeurological - Pain managementACTRN12606000403538Avigen, Inc.36